化学
神经保护
纤维
体外
氧化应激
生物物理学
血脑屏障
自噬
生物化学
药理学
细胞凋亡
神经科学
生物
中枢神经系统
作者
Chenyang Qiu,Ruonan Wei,Jiang Bian,Xin Lin,Tengfei Bai,Jie He,Xiaomin Guo,Yong Chu
标识
DOI:10.1016/j.ejmech.2024.116490
摘要
Parkinson's disease profoundly compromises patients' daily lives, and the disassembly of α-synuclein aggregates, a primary pathological factor, represents a promising therapeutic approach. In this study, we conducted a systematic screening and optimization process to identify the novel scaffold B37, a 4-triazolyl-phenylamine derivative, exhibiting a potent disassembly activity of 1.1 μM against α-synuclein preformed fibrils. Notably, B37 demonstrated significant neuroprotective effects, ameliorated autophagic dysfunction induced by preformed fibrils, mitigated oxidative stress, and restored the co-localization of preformed fibrils with lysosomes. Transmission electron microscopy corroborated its in vitro disassembly function. Pharmacokinetic profiling revealed favorable parameters with a receptible blood-brain barrier permeability. B37 emerges as a promising lead compound for further optimization, aiming to develop a highly effective agent targeting the disassembly of α-synuclein aggregates to treat neurodegenerative diseases like Parkinson's disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI